BMY vs LLY

	BMY Bristol Myers Squibb Co	LLY ELI LILLY & Co
Price	$61.48	$1,273.46
Sector	Health Care	Health Care
X-Ray Score	60	62
Valuation	87	32
Growth	33	90
Profitability	58	62
Financial health	57	69
Dividends	55	63
Fair value	$76	$1,220
Verdict	Undervalued +21%	Fair -7%
Revenue (TTM)	$49.2B	$79.7B
Operating margin	27.7%	42.7%
Return on capital	19.3%	33.9%
Revenue growth (3y)	1.4%	31.7%
Free-cash-flow yield	8.9%	–
Net debt / EBITDA	2.0×	1.3×
Dividend yield	4.0%	0.5%

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.